Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Source updated2026-01-14Last update listed in the registry record
Version history
Changes to this trial
Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
· 1 field changed
Primary outcomes · main study measures
Text edit · unverified significance
− Previous value
measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 6 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 3-6); measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 12 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 9-12)
+ Updated value
measure: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6; measure: Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12
The saved outcome text may be shortened. Check the source for full wording.
Trial